Association between the XRCC1 Polymorphisms and Glioma Risk: A Meta-Analysis of Case-Control Studies

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Jiang, Lei ^a   Fang, Xiao ^a   Bao, Yi ^a   Zhou, Jue Yu ^b   Shen, Xiao Yan ^a   Ding, Mao Hua ^a   Chen, Yi ^a   Hu, Guo Han ^a   Lu, Yi Cheng ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

XRCC1 PROTEIN;

ARTICLE; ASIAN; CANCER RISK; CASE CONTROL STUDY; CAUCASIAN; ETHNIC DIFFERENCE; GENETIC ASSOCIATION; GENETIC RISK; GLIOBLASTOMA; GLIOMA; HETEROZYGOTE; HOMOZYGOTE; HUMAN; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM; XRCC1 GENE;

CASE-CONTROL STUDIES; DNA-BINDING PROTEINS; GENETIC ASSOCIATION STUDIES; GLIOBLASTOMA; GLIOMA; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK;

EID: 84873872999     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0055597     Document Type: Article

References (64)

1. Ohgaki H, (2009) Epidemiology of brain tumors. Methods Mol Biol 472: 323-342.
2. Ohgaki H, Kleihues P, (2005) Epidemiology and etiology of gliomas. Acta Neuropathol 109: 93-108.
3. Wood RD, Mitchell M, Sgouros J, Lindahl T, (2001) Human DNA repair genes. Science 291: 1284-1289.
4. Caldecott KW, Tucker JD, Stanker LH, Thompson LH, (1995) Characterization of the XRCC1-DNA ligase III complex in vitro and its absence from mutant hamster cells. Nucleic Acids Res 23: 4836-4843.
5. Kubota Y, Nash RA, Klungland A, Schar P, Barnes DE, et al. (1996) Reconstitution of DNA base excision-repair with purified human proteins: interaction between DNA polymerase beta and the XRCC1 protein. EMBO J 15: 6662-6670.
6. Caldecott KW, McKeown CK, Tucker JD, Ljungquist S, Thompson LH, (1994) An interaction between the mammalian DNA repair protein XRCC1 and DNA ligase III. Mol Cell Biol 14: 68-76.
7. Shen MR, Jones IM, Mohrenweiser H, (1998) Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans. Cancer Res 58: 604-608.
8. Han X, Xing Q, Li Y, Sun J, Ji H, et al. (2012) Study on the DNA Repair Gene XRCC1 and XRCC3 Polymorphism in Prediction and Prognosis of Hepatocellular Carcinoma Risk. Hepatogastroenterology 59.
9. Wang R, Hu X, Zhou Y, Feng Q, Su L, et al. (2012) XRCC1 Arg399Gln and Arg194Trp polymorphisms in childhood acute lymphoblastic leukemia risk: a meta-analysis. Leuk Lymphoma.
10. Qian B, Zhang H, Zhang L, Zhou X, Yu H, et al. (2011) Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer 73: 138-146.
11. Doecke J, Zhao ZZ, Pandeya N, Sadeghi S, Stark M, et al. (2008) Polymorphisms in MGMT and DNA repair genes and the risk of esophageal adenocarcinoma. Int J Cancer 123: 174-180.
12. Hong YC, Lee KH, Kim WC, Choi SK, Woo ZH, et al. (2005) Polymorphisms of XRCC1 gene, alcohol consumption and colorectal cancer. Int J Cancer 116: 428-432.
13. Tae K, Lee HS, Park BJ, Park CW, Kim KR, et al. (2004) Association of DNA repair gene XRCC1 polymorphisms with head and neck cancer in Korean population. Int J Cancer 111: 805-808.
14. Wang L, Yin F, Xu X, Hu X, Zhao D, (2012) X-ray repair cross-complementing group 1 (XRCC1) genetic polymorphisms and risk of childhood acute lymphoblastic leukemia: a meta-analysis. PLoS One 7: e34897.
15. Zhou LQ, Ma Z, Shi XF, Yin XL, Huang KX, et al. (2011) Polymorphisms of DNA repair gene XRCC1 and risk of glioma: a case-control study in Southern China. Asian Pac J Cancer Prev 12: 2547-2550.
16. Yosunkaya E, Kucukyuruk B, Onaran I, Gurel CB, Uzan M, et al. (2010) Glioma risk associates with polymorphisms of DNA repair genes, XRCC1 and PARP1. Br J Neurosurg 24: 561-565.
17. Rajaraman P, Hutchinson A, Wichner S, Black PM, Fine HA, et al. (2010) DNA repair gene polymorphisms and risk of adult meningioma, glioma, and acoustic neuroma. Neuro Oncol 12: 37-48.
18. McKean-Cowdin R, Barnholtz-Sloan J, Inskip PD, Ruder AM, Butler M, et al. (2009) Associations between polymorphisms in DNA repair genes and glioblastoma. Cancer Epidemiol Biomarkers Prev 18: 1118-1126.
19. Liu Y, Scheurer ME, El-Zein R, Cao Y, Do KA, et al. (2009) Association and interactions between DNA repair gene polymorphisms and adult glioma. Cancer Epidemiol Biomarkers Prev 18: 204-214.
20. Kiuru A, Lindholm C, Heinavaara S, Ilus T, Jokinen P, et al. (2008) XRCC1 and XRCC3 variants and risk of glioma and meningioma. J Neurooncol 88: 135-142.
21. Cengiz SL, Acar H, Inan Z, Yavuz S, Baysefer A, (2008) Deoxy-ribonucleic acid repair genes XRCC1 and XPD polymorphisms and brain tumor risk. Neurosciences (Riyadh) 13: 227-232.
22. Felini MJ, Olshan AF, Schroeder JC, North KE, Carozza SE, et al. (2007) DNA repair polymorphisms XRCC1 and MGMT and risk of adult gliomas. Neuroepidemiology 29: 55-58.
23. Wang LE, Bondy ML, Shen H, El-Zein R, Aldape K, et al. (2004) Polymorphisms of DNA repair genes and risk of glioma. Cancer Res 64: 5560-5563.
24. Wang D, Hu Y, Gong H, Li J, Ren Y, et al. (2012) Genetic polymorphisms in the DNA repair gene XRCC1 and susceptibility to glioma in a Han population in northeastern China: a case-control study. Gene 509: 223-227.
25. Bethke L, Webb E, Murray A, Schoemaker M, Johansen C, et al. (2008) Comprehensive analysis of the role of DNA repair gene polymorphisms on risk of glioma. Hum Mol Genet 17: 800-805.
26. Hu XB, Feng Z, Fan YC, Xiong ZY, Huang QW, (2011) Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to glioma. Asian Pac J Cancer Prev 12: 2981-2984.
27. Custodio AC, Almeida LO, Pinto GR, Santos MJ, Almeida JR, et al. (2011) Analysis of the polymorphisms XRCC1Arg194Trp and XRCC1Arg399Gln in gliomas. Genet Mol Res 10: 1120-1129.
28. Liu J, Sun H, Huang L, Hu P, Dai X, (2011) Relationship between XRRC1 polymorphisms and adult gliomas. Mod Pre Med 38: 3340-3341.
29. Cochran W, (1954) The combination of estimates from different experiments. Biometrics 10: 101-129.
30. Higgins JP, Thompson SG, Deeks JJ, Altman DG, (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560.
31. Mantel N, Haenszel W, (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748.
32. DerSimonian R, Laird N, (1986) Meta-analysis in clinical trials. Control Clin Trials 7: 177-188.
33. Egger M, Davey Smith G, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
34. Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S, (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73: 39-85.
35. Goode EL, Ulrich CM, Potter JD, (2002) Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol Biomarkers Prev 11: 1513-1530.
36. Monaco R, Rosal R, Dolan MA, Pincus MR, Brandt-Rauf PW, (2007) Conformational effects of a common codon 399 polymorphism on the BRCT1 domain of the XRCC1 protein. Protein J 26: 541-546.
37. Moullan N, Cox DG, Angele S, Romestaing P, Gerard JP, et al. (2003) Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy. Cancer Epidemiol Biomarkers Prev 12: 1168-1174.
38. Hamajima N, Takezaki T, Tajima K, (2002) Allele Frequencies of 25 Polymorphisms Pertaining to Cancer Risk for Japanese, Koreans and Chinese. Asian Pac J Cancer Prev 3: 197-206.
39. Li Y, Liu F, Tan SQ, Wang Y, Li SW, (2012) X-Ray Repair Cross-Complementing Group 1 (XRCC1) Genetic Polymorphisms and Cervical Cancer Risk: A HuGE Systematic Review and Meta-Analysis. PLoS One 7: e44441.
40. Saadat M, Ansari-Lari M, (2009) Polymorphism of XRCC1 (at codon 399) and susceptibility to breast cancer, a meta-analysis of the literatures. Breast Cancer Res Treat 115: 137-144.
41. Li H, Ha TC, Tai BC, (2009) XRCC1 gene polymorphisms and breast cancer risk in different populations: a meta-analysis. Breast 18: 183-191.
42. Wu K, Su D, Lin K, Luo J, Au WW, (2011) XRCC1 Arg399Gln gene polymorphism and breast cancer risk: a meta-analysis based on case-control studies. Asian Pac J Cancer Prev 12: 2237-2243.
43. Geng J, Zhang Q, Zhu C, Wang J, Chen L, (2009) XRCC1 genetic polymorphism Arg399Gln and prostate cancer risk: a meta-analysis. Urology 74: 648-653.
44. Wei B, Zhou Y, Xu Z, Ruan J, Zhu M, et al. (2011) XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis. Prostate Cancer Prostatic Dis 14: 225-231.
45. Wang B, Wang D, Huang G, Zhang C, Xu DH, et al. (2010) XRCC1 polymorphisms and risk of colorectal cancer: a meta-analysis. Int J Colorectal Dis 25: 313-321.
46. Wang C, Sun Y, Han R, (2008) XRCC1 genetic polymorphisms and bladder cancer susceptibility: a meta-analysis. Urology 72: 869-872.
47. Huang J, Zhang J, Zhao Y, Liao B, Liu J, et al. (2011) The Arg194Trp polymorphism in the XRCC1 gene and cancer risk in Chinese Mainland population: a meta-analysis. Mol Biol Rep 38: 4565-4573.
48. Dai L, Duan F, Wang P, Song C, Wang K, et al. (2012) XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies. Mol Biol Rep 39: 9535-9547.
49. Jiang J, Liang X, Zhou X, Huang R, Chu Z, et al. (2010) DNA repair gene X-ray repair cross complementing group 1 Arg194Trp polymorphism on the risk of lung cancer: a meta-analysis on 22 studies. J Thorac Oncol 5: 1741-1747.
50. Dai L, Wang K, Zhang J, Lv Q, Wu X, et al. (2009) XRCC1 gene polymorphisms and esophageal squamous cell carcinoma risk in Chinese population: A meta-analysis of case-control studies. Int J Cancer 125: 1102-1109.
51. Chen B, Zhou Y, Yang P, Wu XT, (2012) Polymorphisms of XRCC1 and gastric cancer susceptibility: a meta-analysis. Mol Biol Rep 39: 1305-1313.
52. Zhou C, Zhou Y, Li J, Zhang Y, Jiang L, et al. (2009) The Arg194Trp polymorphism in the X-ray repair cross-complementing group 1 gene as a potential risk factor of oral cancer: a meta-analysis. Tohoku J Exp Med 219: 43-51.
53. Zhang H, Li W, Franklin MJ, Dudek AZ, (2011) Polymorphisms in DNA repair gene XRCC1 and skin cancer risk: a meta-analysis. Anticancer Res 31: 3945-3952.
54. Xie T, Wang ZG, Zhang JL, Liu H, (2012) X-ray repair cross-complementing group 1 polymorphisms and hepatocellular carcinoma: A meta-analysis. World J Gastroenterol 18: 4207-4214.
55. Wei X, Chen D, Lv T (2012) A functional polymorphism in XRCC1 is associated with glioma risk: evidence from a meta-analysis. Mol Biol Rep.
56. Jacobs DI, Bracken MB, (2012) Association between XRCC1 polymorphism 399 G- >A and glioma among Caucasians: a systematic review and meta-analysis. BMC Med Genet 13: 97.
57. Sun JY, Zhang CY, Zhang ZJ, Dong YF, Zhang AL, et al. (2012) Association Between XRCC1 Gene Polymorphisms and Risk of Glioma Development: A Meta-analysis. Asian Pac J Cancer Prev 13: 4783-4788.
58. Blair A, Burg J, Foran J, Gibb H, Greenland S, et al. (1995) Guidelines for application of meta-analysis in environmental epidemiology. ISLI Risk Science Institute. Regul Toxicol Pharmacol 22: 189-197.
59. Johansen HK, Gotzsche PC, (1999) Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis. JAMA 282: 1752-1759.
60. Tramer MR, Reynolds DJ, Moore RA, McQuay HJ, (1997) Impact of covert duplicate publication on meta-analysis: a case study. BMJ 315: 635-640.
61. Zhang X, Miao X, Liang G, Hao B, Wang Y, et al. (2005) Polymorphisms in DNA base excision repair genes ADPRT and XRCC1 and risk of lung cancer. Cancer Res 65: 722-726.
62. Chacko P, Rajan B, Joseph T, Mathew BS, Pillai MR, (2005) Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer. Breast Cancer Res Treat 89: 15-21.
63. Pachouri SS, Sobti RC, Kaur P, Singh J, (2007) Contrasting impact of DNA repair gene XRCC1 polymorphisms Arg399Gln and Arg194Trp on the risk of lung cancer in the north-Indian population. DNA Cell Biol 26: 186-191.
64. Curtin K, Samowitz WS, Wolff RK, Ulrich CM, Caan BJ, et al. (2009) Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer. Cancer Epidemiol Biomarkers Prev 18: 3384-3388.